Advances in antitumor effects of pterostilbene and its derivatives

Area of Science:

• Pharmacology
• Natural Products Chemistry
• Oncology

Background:

• Pterostilbene (PT), a stilbenoid, is recognized for its potential anti-cancer properties.
• Tumor diseases represent a significant global health challenge, necessitating novel therapeutic strategies.

Purpose of the Study:

• To comprehensively review the antitumor effects of pterostilbene and its derivatives.
• To summarize recent advancements (last 20 years) in PT's efficacy across diverse cancer types.
• To explore structure-activity relationships and clinical applications for stilbene compounds.

Main Methods:

• Literature review of studies published in the last 20 years.
• Analysis of research on pterostilbene and its derivatives in various cancer models.
• Synthesis of information on structure-activity relationships (SAR) and clinical applications.

Main Results:

• Pterostilbene derivatives demonstrate enhanced anti-tumor efficacy compared to native pterostilbene.
• Significant anti-cancer effects were observed in colon, breast, liver, lung, and pancreatic cancer models.
• Key SAR rules and potential clinical application methods were identified.

Conclusions:

• Pterostilbene and its derivatives represent a promising class of compounds for cancer therapy.
• Understanding SAR is crucial for designing more potent and clinically viable stilbene-based anti-cancer drugs.
• Further research into chemical modification and clinical translation is warranted.